Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

137.08
-8.0456-5.54%
Volume:22.46M
Turnover:3.05B
Market Cap:54.73B
PE:-17.12
High:145.49
Open:142.70
Low:130.00
Close:145.13
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:0.53
T/O Rate:6.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.09
PE(LYR):-18.88

Loading ...

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

Reuters
·
Jun 23

Moderna Down Over 9%, on Pace for Largest Percent Decrease Since May 2025 -- Data Talk

Dow Jones
·
Jun 22

Moderna Shares Down 7.4% Following Near 40% Surge in Past Six Sessions

THOMSON REUTERS
·
Jun 22

Stock Track | Moderna Plummets 6.37% Intraday as Profit-Taking Emerges After 39% Rally, Analysts Maintain Skeptical Stance

Stock Track
·
Jun 22

Movement Alert|Moderna Falls 5.34% in Regular Trading, Investment Bank Maintains Underperform Rating After 39% Rally

Market Focus
·
Jun 22

Moderna : Leerink Partners Raises Target Price to $24 From $21

THOMSON REUTERS
·
Jun 22

RPT-BUZZ-US stocks weekly: Recovery

Reuters
·
Jun 22

Leerink Partners Adjusts Price Target on Moderna to $24 From $21, Maintains Underperform Rating

MT Newswires Live
·
Jun 22

Barclays Sticks to Its Hold Rating for Moderna (MRNA)

TIPRANKS
·
Jun 22

U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon

Reuters
·
Jun 22

Analysts Conflicted on These Healthcare Names: AbbVie (ABBV) and Moderna (MRNA)

TIPRANKS
·
Jun 22

Weekly Winners | WDC Soars 32%; MRNA Surges 28%; GEV Jumps 18%; HOOD Rallies 16%

Tiger Newspress
·
Jun 21

Under the Radar: Moderna Stock Rises on Flu-Shot Recommendation -- WSJ

Dow Jones
·
Jun 19

Moderna Reports Unanimous FDA Panel Backing for Flu Vaccine

MT Newswires Live
·
Jun 19

Moderna announces FDA advisory committee votes in favor of mRNA-1010

TIPRANKS
·
Jun 19

Moderna: FDA Prescription Drug User Fee Act (Pdufa) Goal Date Remains August 5, 2026

THOMSON REUTERS
·
Jun 19

Moderna Says FDA Advisory Committee Votes Unanimously in Favor of Benefit-Risk Profile of Mrna-1010, an Investigational Seasonal Influenza Vaccine

THOMSON REUTERS
·
Jun 19

Moderna up 4% after FDA advisers back flu vaccine approval

TIPRANKS
·
Jun 19

Market Chatter: Moderna's Flu Shot Wins Support From FDA Advisers

MT Newswires Live
·
Jun 19

Jefferies’ confidence in Moderna’s mRNA flu shot rises after AdCom support

TIPRANKS
·
Jun 19